Morgan Stanley’s Jasper Therapeutics JSPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Buy |
769,750
+115,766
| +18% | +$643K | ﹤0.01% | 4183 |
|
|
2025
Q1 | $2.81M | Buy |
653,984
+49,192
| +8% | +$212K | ﹤0.01% | 4383 |
|
|
2024
Q4 | $12.9M | Buy |
604,792
+39,070
| +7% | +$835K | ﹤0.01% | 3170 |
|
|
2024
Q3 | $10.6M | Buy |
565,722
+256,303
| +83% | +$4.82M | ﹤0.01% | 3384 |
|
|
2024
Q2 | $7.02M | Buy |
309,419
+133,002
| +75% | +$3.02M | ﹤0.01% | 3610 |
|
|
2024
Q1 | $5.18M | Sell |
176,417
-163,493
| -48% | -$4.8M | ﹤0.01% | 3886 |
|
|
2023
Q4 | $2.68M | Buy |
339,910
+261,822
| +335% | +$2.07M | ﹤0.01% | 4767 |
|
|
2023
Q3 | $547K | Buy |
78,088
+45,933
| +143% | +$322K | ﹤0.01% | 5128 |
|
|
2023
Q2 | $441K | Sell |
32,155
-5,652
| -15% | -$77.4K | ﹤0.01% | 5283 |
|
|
2023
Q1 | $684K | Buy |
37,807
+37,502
| +12,296% | +$679K | ﹤0.01% | 5074 |
|
|
2022
Q4 | $1.47K | Sell |
305
-8
| -3% | -$39 | ﹤0.01% | 7416 |
|
|
2022
Q3 | $2K | Buy |
313
+13
| +4% | +$83 | ﹤0.01% | 7473 |
|
|
2022
Q2 | $6K | Sell |
300
-128
| -30% | -$2.56K | ﹤0.01% | 7361 |
|
|
2022
Q1 | $15K | Sell |
428
-29,451
| -99% | -$1.03M | ﹤0.01% | 7262 |
|
|
2021
Q4 | $2.35M | Buy |
29,879
+18,993
| +174% | +$1.49M | ﹤0.01% | 4455 |
|
|
2021
Q3 | $1.12M | Buy |
+10,886
| New | +$1.12M | ﹤0.01% | 4981 |
|